We investigated the molecular and immune landscape of three chondrosarcoma subtypes using a large database of clinical-grade sequencing results ... PD-L1–positive is defined as a TPS of 1% or more.
To identify potential therapeutic targets, this study investigated the molecular and immune landscape of three chondrosarcoma subtypes using a large database of clinical-grade sequencing results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback